Scilex Holding - Accounting Book Value Bawat Bahagi SCLX
Ang Scilex Holding Company (SCLX) ay isang biopharmaceutical player na bumubuo ng mga solusyon para sa non-opioid pain management. Ang mga protektadong patent at konsistent na demand ay nagsisiguro ng mataas na margin at isang matatag na cash flow, na kasalukuyang nasa -43.64. Ang price chart na ito sa GURU.Markets ay kumukumpleto sa data ng kita mula sa pagbebenta ng mga makabagong spray at patch. Ang environmental policy ng kumpanya ay nakatuon sa wastong pagtatapon ng basura at sa unti-unting pagbabawas ng carbon footprint nito.
%20Stockholders%20Equity%20Bawat%20Bahagi&width=1200&height=400&colorIndex=0&v=mvujvhid.si-7ayy9s0&start=20220704&end=20261030&filename=GURU_Markets_-_SCLX_-_Scilex-Holding-Company_-_Equity-per-Share "Scilex Holding Company, Inc. (SCLX) - Netong Asset Bawat Isang Bahagi mula 28.04.2023 hanggang 30.10.2026 | 👁️GURU.Markets👁️")
Buod ng mga analytical breakdown ng data para sa scilexholding.com (SCLX)
- kasalukuyang mga quote at average na pagtataya ng halaga:
- impormasyon sa market value ng issuer:
- mga indicator ng net asset value ayon sa balance sheet:
- mga indicator ng pasanin sa utang at liquidity:
Ratio ng Kabuuang Utang sa Stockholders Equity Scilex Holding Company|SCLX - Pangmatagalang utang sa kapital|Panandaliang utang sa equity Scilex|SCLX - Mga pinagsamang obligasyon sa utang|Ratio ng utang sa book capitalization Scilex|SCLX - Pangmatagalang utang|Panandaliang utang ng kumpanya Scilex Holding Company|Quick Ratio scilexholding.com
- datos sa kita at mga multiple:
Pangkalahatang pagsusuri ng kumpanya:SCLX - Scilex Holding Co.
Para sa Scilex Holding Company (SCLX), kasama ang scalable distribution network nito para sa mga analgesic patch, ang iniulat na book value per share ay nagsisilbing indikasyon ng net asset capitalization. Ang metric na ito ay kinakalkula bilang pagkakaiba sa pagitan ng kabuuang assets at liabilities na hinahati sa bilang ng shares outstanding, na nagpapahintulot sa mga mamumuhunan na tukuyin ang intrinsic value ng negosyo at suriin ang margin of safety sa panahon ng mga market correction.
Mga pangunahing kakumpitensya
BIIB - Netong Asset Bawat Isang Bahagi|NBIX: Netong Asset Bawat Isang Bahagi|RGC (Regencell Bioscience) - Accounting Book Value Bawat Bahagi|Stockholders Equity Bawat Bahagi AXSM|Netong Asset Bawat Isang Bahagi ACADIA Pharmaceuticals Inc.|Stockholders Equity Bawat Bahagi XENE (Xenon Pharmaceuticals Inc.)|Book Value Bawat Bahagi VKTX|SUPN - Net Asset Value Bawat Bahagi|Catalyst Pharmaceuticals - Accounting Book Value Bawat Bahagi|Book Value Bawat Bahagi denalitherapeutics.com DNLI|HRMY - Netong Asset Bawat Isang Bahagi|Accounting Value ng Bahagi BHVN (Biohaven Ltd)|Amylyx (AMLX) - Netong Asset Bawat Isang Bahagi|Net Asset Value Bawat Bahagi Trevi Corp (TRVI)|Netong Asset Bawat Isang Bahagi Praxis Precision Medicines|anavex.com (AVXL) - Net Assets Bawat Bahagi|Book Value Bawat Bahagi CBLL|Accounting Book Value Bawat Bahagi Prothena Corporation PRTA|Book Value Bawat Bahagi ALEC (Alector)|Net Assets Bawat Bahagi Annexon Biosciences Inc. (ANNX)|OMER - Netong Asset Bawat Isang Bahagi|NGNE: Netong Asset Bawat Isang Bahagi|ACIU: Book Value Bawat Bahagi|Net Asset Value Bawat Bahagi Voyager Therapeutics Inc (VYGR)|Accounting Book Value Bawat Bahagi NMRA|Stockholders Equity Bawat Bahagi TVGN (Tevogen Bio Inc.)|Accounting Book Value Bawat Bahagi ACOG (Alpha Cognition)|CGTX (Cognition Therapeutics Inc.) - Accounting Value ng Bahagi|Book Value Bawat Bahagi IKT (Inhibikase Therapeutics, Inc.)|Accounting Value ng Bahagi SAVA|ASRT - Netong Asset Bawat Isang Bahagi|Net Asset Value Bawat Bahagi Coya Therapeutics, Inc.|vistagen.com (VTGN) - Netong Asset Bawat Isang Bahagi|OVID (Ovid Therapeutics) - Netong Asset Bawat Isang Bahagi|ABOS (Acumen Pharmaceuticals, Inc.) - Book Value Bawat Bahagi|Stockholders Equity Bawat Bahagi CRVO (CervoMed, Inc.)|Book Value Bawat Bahagi ATHE|Net Assets Bawat Bahagi clene.com|Netong Asset Bawat Isang Bahagi PepGen PEPG|JUNS: Stockholders Equity Bawat Bahagi|Relmada Therapeutics, Inc. - Book Value Bawat Bahagi|Book Value ng Isang Bahagi Annovis Bio Inc (ANVS)|GRCE (gracetx.com) - Accounting Book Value Bawat Bahagi|Firefly Neuro - Accounting Value ng Bahagi|KLTO (ANEW Medical) - Book Value Bawat Bahagi|Accounting Book Value Bawat Bahagi NeuroSense Therapeutics, Ltd. (NRSN)|Netong Asset Bawat Isang Bahagi Reviva Pharmaceuticals Holdings, Inc. (RVPH)|MTVA - Net Asset Value Bawat Bahagi|Netong Asset Bawat Isang Bahagi NeurAxis, Inc NRXS|HSDT - Accounting Book Value Bawat Bahagi|PASG - Netong Asset Bawat Isang Bahagi|Book Value ng Bahagi NEUP|NERV: Book Value Bawat Bahagi|Athira Pharma Inc (ATHA) - Book Value Bawat Bahagi|Netong Asset Bawat Isang Bahagi Addex Therapeutics, Ltd.|Stockholders Equity Bawat Bahagi ALZN (Alzamend)|Accounting Book Value Bawat Bahagi CYCN (Cyclerion Therapeutics)|PTIX - Net Asset Value Bawat Bahagi|Netong Asset Bawat Isang Bahagi Pasithea Therapeutics Corp. KTTA|Net Assets Bawat Bahagi Cortigent Inc (CRGT)|Avenue Therapeutics, Inc - Book Value Bawat Bahagi|BrainStorm Cell Therapeutics Inc. (BCLI) - Accounting Book Value Bawat Bahagi|Cara Therapeutics, Inc. (CARA) - Netong Asset Bawat Isang Bahagi|CHRO (chromocell.com) - Netong Asset Bawat Isang Bahagi|Accounting Book Value Bawat Bahagi ELYM|Stockholders Equity Bawat Bahagi ITCI (Intra-Cellular)|Netong Asset Bawat Isang Bahagi Longboard Pharma (LBPH)|Marinus Pharma - Stockholders Equity Bawat Bahagi|Book Value Bawat Bahagi NKGN (NKGen Biotech, Inc.)|neurobopharma.com (NRBO) - Net Asset Value Bawat Bahagi|SAGE: Accounting Book Value Bawat Bahagi|SNPX - Book Value Bawat Bahagi|Trevena, Inc (TRVN) - Netong Asset Bawat Isang Bahagi|Vigil Neuroscience, Inc. - Accounting Value ng Bahagi|Netong Asset Bawat Isang Bahagi Anew Medical|Net Asset Value Bawat Bahagi cerevel.com CERE